RecruitingNot ApplicableNCT05386342

A PMCF Study Confirm the Performance and Safety of the TufTex Over-the-Wire (OTW) Embolectomy Catheters

A Post-market Clinical Study to Confirm the Performance and Safety of the LeMaitre TufTex Over-the-Wire (OTW) Embolectomy Catheter on Patients Undergoing Surgical Treatment for the Removal of Arterial Emboli and/or Thrombi


Sponsor

LeMaitre Vascular

Enrollment

112 participants

Start Date

Jan 11, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

A PMCF study to confirm the performance and safety of the LeMaitre® TufTex Over-the-Wire Embolectomy Catheter


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called TufTex Over-the-Wire Embolectomy Catheter for people with embolus, occlusion; vessel, and other related conditions. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETufTex Over-the-Wire Embolectomy Catheter

The OTW Catheter can be used for the removal of emboli and thrombi. It can also be used for catheter placement over a guidewire, vessel occlusion, fluid infusion and/or aspiration.


Locations(3)

Andrej Udelnow

Brandenburg, Germany

University Hospital Carl Gustav Carus TU Dresden

Dresden, Germany

Ospedale Regionale di Lugano - sede Civico

Lugano, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05386342


Related Trials